Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.
about
Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infectionUltrasensitive detection of proteins and sugars at single-cell levelPoint of Care Technologies for HIVAn urgent need for introduction of fourth-generation Ag-Ab based EIA for detection of HIV infectionThe characteristics of screening and confirmatory test results for HIV in Xi'an, China.HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043).Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results.Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.ru2hot?: A public health education campaign for men who have sex with men to increase awareness of symptoms of acute HIV infection.Finding those at risk: acute HIV infection in Newark, NJ.Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants.Prolonged second diagnostic window for human immunodeficiency virus type 1 in a fourth-generation immunoassay: are alternative testing strategies required?Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San FranciscoAvidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassaysBrief Report: Health-Seeking Behavior and Symptoms Associated With Early HIV Infection: Results From a Population-Based Cohort in Southern MalawiDetection of HIV-1 p24 at Attomole Level by Ultrasensitive ELISA with Thio-NAD Cycling.HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men.Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithmUse of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 StudyCosts per Diagnosis of Acute HIV Infection in Community-based Screening Strategies: A Comparative Analysis of Four Screening AlgorithmsPerformance of Determine Combo and other point-of-care HIV tests among Seattle MSM.Will gay and bisexually active men at high risk of infection use over-the-counter rapid HIV tests to screen sexual partners?Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infectionRelative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men.Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population.Diagnosing acute HIV infection.Performances of four fourth-generation human immunodeficiency virus-1 screening assays.Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing.HIV testing: current practice and future directions.Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories.A portable paper-based microfluidic platform for multiplexed electrochemical detection of human immunodeficiency virus and hepatitis C virus antibodies in serumEvaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection.A rapid ultrasound particle agglutination method for HIV antibody detection: Comparison with conventional rapid HIV tests.Quarantine Plasma: Quo vadis?Comparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.HIV testing updates and challenges: when regulatory caution and public health imperatives collide.The Performance of the Abbott i2000 for Measuring Serum Markers of Infectious Diseases.Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay - evaluation of a new HIV assay.Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States.Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.
P2860
Q24607025-9C49369D-8254-4DB9-8412-418BF7AC8BC1Q26750466-BE0864EC-D953-4BB5-978F-C6F9EE4E8287Q30442547-DA5B36A2-2611-47B7-A754-217F0D158976Q33745422-F8D20E53-6427-4B15-9EC4-880D5B8F5AC7Q33883784-D880C394-E701-4A2C-B2F6-0534190373AEQ34028918-8D823AC0-BE7A-4750-85F0-0DA9792E820EQ34070855-EBC31298-9CA9-4E76-9A54-5E449FC97E94Q34400923-E93E95EE-48E6-48DB-A12F-92DEB8BA3A20Q34640702-E9964A44-43F6-4C98-89DE-D576A55D17EDQ34701577-E211B0A5-F3D2-45CF-8044-C8FEAB6A5F3FQ35035727-E3C64797-5E75-421A-8B41-4B784D6E70B9Q35036131-11091FBA-D4B9-4017-8609-9422135785FAQ35069399-799F5F52-0B73-4668-A096-EAAF6A9DF033Q35140064-EC39BFBF-C5D9-4E71-AF66-A79B996202F6Q35575969-9F99E402-D36D-49AE-943A-BE9FAE2A5B71Q35670640-6A644064-F24F-4C37-930C-E2EB591F611FQ36084431-4FAADDB0-1506-478A-858F-155ED441DE06Q36092039-0A0A8FE0-0226-41EC-9E1B-E2B0A2B11899Q36495534-911EDC55-4646-4E4F-A5BC-872E60F36F90Q36497859-5479E025-D62D-4AC9-8860-EA0BAB923ECDQ36604715-C0BDA50E-9259-4FCB-8D3C-D44CB1CB6C69Q36694021-20DF7099-EE92-4F1C-887A-8060BD11CC11Q36886845-4585CF1F-4904-49E6-B528-3BCA0C0F5158Q37402661-4873A42D-502D-4850-B802-15F440DD0F15Q37692346-1C8BA584-0929-4AF0-A14A-51D7ED9C184CQ37965692-6933AF55-0E4E-4653-9A3F-EC994B2214EEQ38457263-E37B0819-B2B7-4D35-8587-E68004416957Q39150244-8610EC92-6C1C-4F84-A0E0-BCC4D6352934Q39445877-1ACFCDF8-E75B-4F07-9C9E-099DE727A927Q39727750-933E574B-1E81-43EB-9AC4-C09A4609D119Q39784095-6F00AAFF-FA46-4F68-9650-06473C5B1DC8Q40067996-35357680-333D-4F1C-9D1A-FA0AF9D17DAFQ40069316-CCF9772E-977D-4FE3-B667-76EA1ECEE2E4Q41269653-F77DFBF9-C0BE-4C64-BA4C-653481AE93DAQ41280296-9204771F-4459-4BE3-BBAA-BABC64C2B40FQ41500321-F214CDB3-9AC2-471B-8622-723F3F835688Q42103229-5A30852A-9792-4FE9-AB59-17928D0C0436Q42274760-F68A9554-2CDC-4918-982B-C653F7E63F7EQ45359891-9D6B33E5-FD93-4B1E-8450-35E11ACF173DQ45374189-E24218E7-CED6-4C67-8DBA-8D55E074AB50
P2860
Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Assessment of the ability of a ...... ctions in a high-risk setting.
@en
Assessment of the ability of a ...... r human immunodeficiency virus
@nl
type
label
Assessment of the ability of a ...... ctions in a high-risk setting.
@en
Assessment of the ability of a ...... r human immunodeficiency virus
@nl
prefLabel
Assessment of the ability of a ...... ctions in a high-risk setting.
@en
Assessment of the ability of a ...... r human immunodeficiency virus
@nl
P2093
P2860
P356
P1476
Assessment of the ability of a ...... ctions in a high-risk setting.
@en
P2093
Ana Vallari
Brian Louie
John Hackett
Mark W Pandori
Sally Liska
Teri Dowling
P2860
P304
P356
10.1128/JCM.00119-09
P407
P577
2009-06-17T00:00:00Z